Market landscape of penicillin for syphilis and rheumatic heart disease, WHO South-East Asia Region
Gereltuya Dorj, Uhjin Kim, Po-Lin Chan, Pradeep Joshi, Abhishek Royal, Karina Razali · 2026
Read Market landscape of penicillin for syphilis and rheumatic heart disease, WHO South-East Asia Region by Gereltuya Dorj, Uhjin Kim, Po-Lin Chan, Pradeep Joshi, Abhishek Royal, Karina Razali (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13527684.txt.
Description
Gereltuya Dorj and colleagues mapped penicillin markets for syphilis and rheumatic heart disease across South-East Asia. Published in 2026, the World Health Organization study surveyed five key penicillin drug forms in nine countries, tracking approval, medicine-list status, buying, supply, price, and demand guesses. Reliable penicillin prevents stillbirth and syphilis passed to newborns and holds rheumatic fever at bay.
Prices varied wildly, with one drug form costing over twenty-three times more in Timor-Leste than in Bangladesh, and another varying up to fifty-five-fold across the region. Shortages hit benzathine penicillin in five countries and other drug forms in Sri Lanka and Maldives. Demand runs into hundreds of millions of doses yearly, led by India. The authors call for joint demand guesses, shared rules, and pooled buying to secure fair access.
Catalog record
| CREATOR | Gereltuya Dorj, Uhjin Kim, Po-Lin Chan, Pradeep Joshi, Abhishek Royal, Karina Razali |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |